Welcome to our dedicated page for Firsthand Technology Value Fund news (Ticker: SVVC), a resource for investors and traders seeking the latest updates and insights on Firsthand Technology Value Fund stock.
Firsthand Technology Value Fund, Inc. (OTCQB: SVVC) is a publicly traded venture capital fund that invests in technology and cleantech companies, operating as a non-diversified, closed-end investment company that has elected to be treated as a business development company. The Fund regularly issues press releases detailing its financial results, portfolio valuation changes, and other significant developments, which form the core of the news flow associated with SVVC.
News about Firsthand Technology Value Fund frequently covers quarterly and annual financial results, including net asset value (NAV) per share, net assets, and the composition of its portfolio across equity and debt investments, cash and cash equivalents, and other assets. These updates often describe how the Valuation Committee, working with an independent valuation firm and following the Fund’s valuation procedures and ASC 820, has adjusted the fair values of private portfolio companies based on performance, recent transactions, and sector market multiples.
Investors following SVVC news can also see disclosures about fee waiver arrangements with its investment adviser, Firsthand Capital Management, Inc., and how these agreements affect reported management fees and net investment income or loss. In addition, the Fund has announced strategic reviews, such as the engagement of Ladenburg Thalmann & Co. Inc. to evaluate strategic options aimed at increasing stockholder value.
This news page aggregates such announcements, giving readers a centralized view of the Fund’s periodic financial reporting, valuation changes, portfolio developments, and Board-level decisions. For those tracking a venture capital-style fund focused on technology and cleantech companies, SVVC news provides insight into how its portfolio and capital structure evolve over time.
The Firsthand Technology Value Fund (NASDAQ: SVVC) announced its top five holdings as of April 30, 2022, comprising IntraOp Medical, Revasum, Wrightspeed, Hera Systems, and Pivotal Systems, which collectively account for 95.5% of the Fund's estimated total investments of approximately $72.3 million, or $10.50 per share. Major investments include 26.9% in IntraOp Medical and 26.8% in Revasum. The Fund focuses on technology and cleantech sectors, and complete financial statements will be available in a quarterly report in August 2022.
Firsthand Technology Value Fund (NASDAQ: SVVC) reported its Q1 2022 financial results, showing net assets of approximately $87.4 million ($12.68 per share), down from $94.8 million ($13.75 per share) at year-end 2021. The Fund's portfolio, including public and private securities, was valued at $82.2 million ($11.93 per share). During Q1, the Fund recorded $1.9 million in investment income, with a net investment income of $1.2 million. However, it suffered net realized and unrealized losses amounting to approximately $8.6 million.
As of March 31, 2022, Firsthand Technology Value Fund (NASDAQ: SVVC) reported a preliminary NAV of $12.68. The Fund's top five holdings include Revasum, IntraOp Medical, Wrightspeed, Hera Systems, and Pivotal Systems, constituting 90.4% of its preliminary net assets. Total investments were $82.2 million, or approximately $11.93 per share. The Fund emphasizes investing in technology and cleantech companies, aiming for long-term capital growth. A full quarterly report will be available in May 2022.
Firsthand Technology Value Fund (NASDAQ: SVVC) disclosed its top five holdings as of February 28, 2022, which include IntraOp Medical (29.4%), Revasum (29.2%), Wrightspeed (25.2%), Hera Systems (6.1%), and Pivotal Systems (5.7%). The Fund's total estimated investments were approximately $92.9 million, or $13.47 per share. These holdings constituted 95.5% of the total investments. A detailed financial statement will be available in the upcoming quarterly report in May 2022. The Fund primarily invests in technology and cleantech companies, aiming for long-term capital growth.
Firsthand Technology Value Fund (NASDAQ: SVVC) reported its financial results for the fiscal year ended December 31, 2021. The Fund's net assets decreased to approximately $94.8 million or $13.75 per share, down from $102.1 million or $14.82 per share in 2020. The portfolio includes $91.1 million in public and private securities, with $0.09 per share in cash equivalents. Investment income was about $6.3 million, but net realized and unrealized losses reached $10.45 million for the year. The Fund's strategy focuses on enhancing portfolio performance and exit opportunities.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced its top five holdings as of January 31, 2022. These include Revasum (32.8%), IntraOp Medical (27.1%), Wrightspeed (23.2%), Pivotal Systems (6.8%), and Hera Systems (5.5%), collectively accounting for 95.3% of the Fund's estimated total investments of approximately $99.9 million or $14.50 per share. The Fund primarily focuses on technology and cleantech investments and plans to release full financial statements in May 2022, detailing its performance and investment strategies.
Firsthand Technology Value Fund (NASDAQ: SVVC) announced its preliminary net asset value (NAV) of $13.75 as of December 31, 2021. The Fund's top five holdings are IntraOp Medical, Wrightspeed, Revasum, Pivotal Systems, and Hera Systems, representing a combined 91.3% of its net assets. Total investments reached $91.1 million, with a per-share valuation of $13.22. The annual report, including detailed financial statements and investment schedules, will be available with the Form 10-K filing in March 2022.
As of November 30, 2021, Firsthand Technology Value Fund (NASDAQ: SVVC) reported estimated total investments of approximately $97.1 million, equating to $14.09 per share. The top five holdings comprise 93.4% of these investments. The leading position is IntraOp Medical Corp., representing about 33.0% of the Fund's investments, followed by Wrightspeed, Revasum, Pivotal Systems, and Hera Systems. Cash and equivalents accounted for $0.28 per share. Comprehensive financial details will be available in the upcoming Form 10-K annual report.
The Firsthand Technology Value Fund (NASDAQ: SVVC) reported its top five holdings as of October 31, 2021, with a total investment value of approximately $105.1 million, or $15.25 per share. Major investments include IntraOp Medical (29.6%), Wrightspeed (23.6%), Revasum (22.8%), Pivotal Systems (10.4%), and Hera Systems (5.6%). These top holdings represent 91.9% of the Fund's total investments. A complete financial report will be available in the Fund’s annual report on Form 10-K by March 2022.
Firsthand Technology Value Fund (NASDAQ: SVVC) reported third-quarter financial results for the period ending September 30, 2021. The Fund's net assets decreased to approximately $98.8 million, or $14.33 per share, down from $107.3 million or $15.57 per share at the end of Q2 2021. The Fund's portfolio, comprised of public and private securities, is valued at $96.5 million. Investment income for the quarter was around $1.5 million, with net realized and unrealized losses of approximately $9.29 million.